Diagnosing lung cancer using etoposide microparticles labeled with ^99mTc

References

• Abe Y, Tanaka N. The Hedgehog signaling networks in lung cancer: the mechanisms and roles in tumor progression and implications for cancer therapy. Biomed Res Int. 2016;2016:7969286.
   PubMed Web of Science ®Google Scholar
• Jimenez-Bonilla JF, Quirce R, Martinez-Rodriguez I, et al. The role of PET/CT molecular imaging in the diagnosis of recurrence and surveillance of patients treated for non-small cell lung cancer. Diagnostics. 2016;6:pii:E36.
   Web of Science ®Google Scholar
• Reddy AT, Lakshmi SP, Reddy RC. PPARγ as a novel therapeutic target in lung cancer. PPAR Res. 2016;2016:8972570.
   PubMed Web of Science ®Google Scholar
• Espina C, Porta M, Schuz J, et al. Environmental and occupational interventions for primary prevention of cancer: a cross-sectorial policy framework. Environ Health Perspect. 2013;121:420–426.
   PubMed Web of Science ®Google Scholar
• Marshall E. Cancer research and the $90 billion metaphor. Science. 2011;331:1540–1541.
   PubMed Web of Science ®Google Scholar
• Pietanza MC, Zimmerman S, Peters S, et al. Seeking new approaches to patients with small cell lung cancer. Am Soc Clin Oncol Educ Book. 2016;35:e477–e482.
   PubMedGoogle Scholar
• Rezonja R, Knez L, Cufer T, et al. Oral treatment with etoposide in small cell lung cancer - dilemmas and solutions. Radiol Oncol. 2013;47:1–13.
   PubMed Web of Science ®Google Scholar
• Schwab KE, Gailloud P, Wyse G, et al. Limitations of magnetic resonance imaging and magnetic resonance angiography in the diagnosis of intracranial aneurysms. Neurosurgery. 2008;63:29–34.
   PubMed Web of Science ®Google Scholar
• Cuccarese MF, Dubach JM, Pfirschke C, et al. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. Nat Commun. 2017;8:14293.
   PubMed Web of Science ®Google Scholar
• Badea CT, Athreya KK, Espinosa G, et al. Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent. PLoS One. 2012;7:e34496.
   PubMed Web of Science ®Google Scholar
• Yang M, Li L, Jiang P, et al. Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells. Proc Natl Acad Sci USA. 2003;100:14259–14262.
   PubMed Web of Science ®Google Scholar
• Hoffman RM, Yang M. Color-coded fluorescence imaging of tumor-host interactions. Nat Protoc. 2006;1:928–935.
   PubMed Web of Science ®Google Scholar
• Yaqoob Z, Psaltis D, Feld MS, et al. Optical phase conjugation for turbidity suppression in biological samples. Nat Photonics. 2008;2:110–115.
   PubMed Web of Science ®Google Scholar
• Chi C, Du Y, Ye J, et al. Intraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multi-modality imaging technology. Theranostics. 2014;154:1072–1084.
   Google Scholar
• Rud E, Baco E, Klotz D, et al. Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial? Eur Urol. 2015;68:487–496.
   PubMed Web of Science ®Google Scholar
• Weissleder R, Pittet MJ. Imaging in the era of molecular oncology. Nature. 2008;452:580–589.
   PubMed Web of Science ®Google Scholar
• Pysz MA, Gambhir SS, Willmann JK. Molecular imaging: current status and emerging strategies. Clin Radiol. 2010;65:500–516.
   PubMed Web of Science ®Google Scholar
• James ML, Gambhir SS. A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev. 2012;92:897–965.
   PubMed Web of Science ®Google Scholar
• Lee D-E, Koo H, Sun I-C, et al. Multifunctional nanoparticles for multimodal imaging and theragnosis. Chem Soc Rev. 2012;41:2656–2672.
   PubMed Web of Science ®Google Scholar
• Huang Y, He S, Cao W, et al. Biomedical nanomaterials for imaging-guided cancer therapy. Nanoscale. 2012;4:6135–6149.
   PubMed Web of Science ®Google Scholar
• Santos do Carmo F, Ricci-Junior E, Cerqueira-Coutinho C, et al. Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerations. Int J Nanomed. 2016;12:53–60.
   PubMed Web of Science ®Google Scholar
• Sarcinelli MA, de Souza Albernaz M, Szwed M, et al. Nanoradiopharmaceuticals for breast cancer imaging: development, characterization, and imaging in inducted animals. Onco Targets Ther. 2016;9:5847–5854.
   PubMed Web of Science ®Google Scholar
• Cerqueira-Coutinho C, Vidal LP, Pinto SR, et al. Drug metabolism: comparison of biodistribution profile of holmium in three different compositions in healthy Wistar rats. Appl Radiat Isot. 2016;112:27–30.
   PubMed Web of Science ®Google Scholar
• Cerqueira-Coutinho CS, De Campo VE, Rossi AL, et al. Comparing in vivo biodistribution with radiolabeling and Franz cell permeation assay to validate the efficacy of both methodologies in the evaluation of nanoemulsions: a safety approach. Nanotechnology. 2016;27:015101.
   PubMed Web of Science ®Google Scholar
• Cerqueira-Coutinho C, Missailidis S, Alessandra-Perini J, et al. Comparison of biodistribution profile of monoclonal antibodies nanoparticles and aptamers in rats with breast cancer. Artif Cells Nanomed Biotechnol. 2016;45:598–601.
   PubMed Web of Science ®Google Scholar
• Pascual L, Sancenon F, Martinez-Manez R, et al. Mesoporous silica as multiple nanoparticles systems for inflammation imaging as nano-radiopharmaceuticals. Micropor Mesopor Materials. 2017;239:426–431.
   Web of Science ®Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33:941–951.
   PubMed Web of Science ®Google Scholar
• De Jong WH, Hagens WI, Krystek P, et al. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008;29:1912–1919.
   PubMed Web of Science ®Google Scholar